Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,

Slides:



Advertisements
Similar presentations
Module 6: Clinical Stage and Grade. Introduction Stage and grade determine prognosis Staging reflects the clinical extent of the tumor Grading a tumor.
Advertisements

T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Polyps – Where do they come from and what do you do with them?!
Amy Schindler 10/18/10.  Endoscopic appearance: Early cancers: superficial plaque, nodule, or ulceration Advanced lesions: strictures, ulcerated masses,
Department of Pathology
Endoscopic Mucosal Resection (EMR)
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Luigi Bonavina,MD Cattedra e U.O. Chirurgia Generale, Policlinico San Donato Università degli Studi di Milano XXIV Congresso Nazionale A.C.O.I. Montecatini.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
The Adenoma/Carcinoma Sequence in the Colon
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
Barrett’s Esophagus Stuart Jon Spechler, M.D. Chief of Gastroenterology, Dallas VA Medical Center; Professor of Medicine, Berta M. and Cecil O. Patterson.
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
Endoscopic Treatment of Barrett’s Esophagus and Early Esophageal Cancer CTOP Retreat 2014 Dartmouth-Hitchcock Medical Center.
Management of Barrett’s oEsophagus
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
In management of Bastaninejad, Shahin MD, Assistant Prof of ORL, TUMS Amir’Alam Hospital.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
NEOPLASIA Dr. Manal Maher Hussein.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Review R4 황은정 / prof. 장영운 경희대학교 의과대학 소화기내과.
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Barrett Esophagus 2008 년도 2 학기 의학과 석. 박사 공통과목 위장관의 외과병리.
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
ENDOSCOPIC MUCOSAL RESECTION OF NON INVASIVE DUODENAL CARCINOID
Comparison Between Definitive Chemoradiotherapy and Esophagectomy in Patients With Clinical Stage I Esophageal Squamous Cell Carcinoma Sachiko Yamamoto MD,
Treatment of superficial neoplastic lesion of esophagus
Matthew D. Rutter, Robert H. Riddell 
Endoscopic Therapy of Early Carcinoma of the Oesophagus
Dr.Amit Gupta Associate Professor Dept. of Surgery
Safety and Efficacy of Secondary Endoscopic Submucosal Dissection for Residual Gastric Carcinoma after Primary Endoscopic Submucosal Dissection Digestion.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Esophageal Adenocarcinoma
Volume 120, Issue 7, Pages (June 2001)
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
2epart EXTRAPULMONARY SMALL CELL CANCER OF THE ESOPHAGUS INTRODUCTION
Bristol Royal Infirmary M.Boal, D. Titcomb 2/2/17
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett’s Esophagus  Ganapathy A. Prasad,
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Volume 149, Issue 7, Pages (December 2015)
Virtual Histology in Everyday Gastrointestinal Endoscopy
Volume 137, Issue 3, Pages (September 2009)
Volume 120, Issue 7, Pages (June 2001)
Endoscopic Mucosal Resection in the Management of Esophageal Neoplasia: Current Status and Future Directions  Vikneswaran Namasivayam, Kenneth K. Wang,
Peter V. Draganov, Andrew Y. Wang, Mohamed O. Othman, Norio Fukami 
Elizabeth Montgomery, Marcia Irene Canto 
Extensive (8 to 12 cm2) Noncircumferential Endoscopic Mucosal Resection for Early Esophageal Cancer  Philippe Monnier, MD, Yves Jaquet, MD, Alexandre.
Matthew D. Rutter, Robert H. Riddell 
Distribution of Body Fat and Its Influence on Esophageal Inflammation and Dysplasia in Patients With Barrett's Esophagus  Eric M. Nelsen, Yujiro Kirihara,
Christopher G. Chapman, MD, Irving Waxman, MD, FASGE  VideoGIE 
Endoscopic Ultrasound: Accuracy in Staging Superficial Carcinomas of the Esophagus  Sabrina Rampado, MD, Paolo Bocus, MD, Giorgio Battaglia, MD, Alberto.
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease  Francis A. Farraye, Robert D. Odze, Jayne.
Superficial adenocarcinoma of the esophagus
Depth of Submucosal Invasion Does Not Predict Lymph Node Metastasis and Survival of Patients With Esophageal Carcinoma  Rami J. Badreddine, Ganapathy.
Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett’s Esophagus and Colorectal Neoplasia  Dennis Yang, Mohamed Othman, Peter.
Novel approach to endoscopic submucosal dissection of a large gastroesophageal junction mass by use of the mucosal bridge technique  Salmaan Jawaid, MD,
Henning Gerke, MD  Gastrointestinal Endoscopy 
Presentation transcript:

Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar, M.D., Louis M. Wongkeesong, M.D., Jason T. Lewis, M.D., Schuyler O. Sanderson, M.D., Lori S. Lutzke, Lynn S. Borkenhagen, and Kenneth K. Wang, M.D. Division of Gastroenterology and Hepatology, and Department of Laboratory Medicine and Anatomic Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota Am J Gastroenterol 2007;102:2380–2386) R3 Lee jae yeon

Introduction - BE

Background Endoscopic mucosal resection (EMR) - popularized for the treatment of early UGI(esophageal and gastric) carcinomas - also has been used for elimination of neoplasia in BE - esophagectomy : significant morbidity and mortality EMR for staging - ideal endoscopic technique to accurately stage neoplastic lesions ~ depth of tumor invasion determines the risk of metastases - most EMRs not able to completely resect neoplastic lesions since the margins of these lesions are not endoscopically visible

Background * significance of neoplastic involvement of mucosal resection margins on histopathology * significance of tumor margins in terms of lymph node involvement EMR   assessed by following esophagectomy Purpose : assess the accuracy of tumor staging by EMR using esophagectomy

Methods Patient : 25 pts, underwent EMR followed by esophagectomy for either high-grade dysplasia or adenocarcinoma arising in a background of Barrett’s esophagus between June 1995 and September 2004 at the Barrett’s Esophagus Unit, Mayo Clinic Pathology assessment Surface maturation, gland architecture, cytologic feature LGDnuclei were hyperchromatic with mild crowding and/or architectural changes, which extended at least focally to the surface HGDmore significant alterations, including greater nuclear irregularities, prominent nucleoli, loss of nuclear polarity with respect to the basement membrane, and gland crowding Invasive adenoca invaded through muscularis mucosae into submucosa

Methods Surgery - Patient referred for esophagectomy Submucosal carcinoma mucosal carcinoma or HGD on EMR underwent esophagectomy when it was determined that their disease could not be adequately managed endoscopically primarily due to extent of disease - Extensive LN dissection was done

Results

25 esophagectomy after EMR - mean age : 66 yr - 19 patients (76%) being men initial endoscopy 19 : nodule (76%) 4 : mass (defined as a raised lesion > than 2 cm in size) (12.5%) 2 : ulcer (6.2%) EUS - 5 using high frequency (20 and 30 MHz) catheter EUS probes in addition to conventional EUS - On EUS examination, a focal lesion could not be identified (uT0) in 14 patients (56%)

Table 1. Comparison of EUS Stage and Endoscopic Mucosal Resection Stage in Patients With Carcinoma (n = 19) EUS did not identify carcinomas 7 was submucosal Ca EUS accurately staged 4 /16 (25%) submucosal carcinomas and none of the 3 mucosal carcinomas “Endosonographic staging of early neoplasia in BE correlates poorly with surgical pathology staging”

Table 2. Surgical Tumor Stage Compared to Endoscopic Mucosal Resection Tumor Stage No pts with negative margin had residual Ca.

Table 3. Association of Margin Status and Presence of Residual Tumor at the EMR Site (at Esophagectomy)

lymphadenopathy EMR pathologyNumber of Metastatic LAPs HGD0/4 mucosal carcinoma0/3 Submucosal carcinoma5 / perigastric LAPs, - 3 periesophageal LAPs  None of these pts had evidence of suspicious LAP evident on pre-op EUS

Figure 2. Negative margin showing gastric cardio-oxyntic mucosa. No specialized Barrett mucosa is present

Figure 3. High grade dysplasia at a lateral mucosal margin. While there is significant atypia present within these glands, there is no effacement of the lamina propria or significant gland fusion to qualify as carcinoma

Figure 1. Intramucosal adenocarinoma confined by muscularis mucosae. There is a lymphoid aggregate at the lower right corner of the field. No invasion into submucosa is present

Figure 4. Deep margin involved by carcinoma. There are malignant glands and single cells present within mucin pools which are present along the deep margin of the specimen

Conclusion EMR appears to be an accurate technique in staging esophageal carcinoma arising in BE when compared to surgical pathology, making it a valuable adjunct to EUS in the management of patients with early esophageal carcinoma EMR may be curative in some patients Negative margins accurately predict the absence of tumor at the EMR site

Conclusion Submucosal carcinomas are associated with a significantly higher rate of positive margins and a higher risk of LN spread compared with mucosal carcinomas and should not be treated with EMR alone EUS staging of early neoplasia in BE correlates poorly with surgical pathology staging